Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.05 USD
Change Today +0.06 / 1.00%
Volume 266.1K
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Susan M. Molineaux Ph.D.

Co-Founder, Chief Executive Officer, President and Director,Calithera Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 3 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Susan M. Molineaux, Ph.D., co-founded Calithera Biosciences, Inc. in March 2010 and has been its Chief Executive Officer and President since March 2010. Dr. Molineaux Co-founded Onyx Therapeutics, Inc. and served as its Chief Scientific Officer since February 2009. Dr. Molineaux served as the Chief Executive Officer at Onyx Therapeutics, Inc. from January 2006 to February 2009, and its Chief Scientific Officer from December 2003 to December 2005 and served as President. ...

Read Full Background

Corporate Headquarters*

343 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-870-1000
Fax: --

Board Members Memberships*

Co-Founder, Chief Executive Officer, President and Director
Director and Chairperson of Nominating & Corporate Governance Committee
Director and Member of Science & Technology Committee


Johns Hopkins University
Smith College
Post-Doctoral Training
Columbia University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$560,000

Stock Options*

Exercisable Options47,003
Unexercisable Options221,732
Total Number of Options268,735

Total Compensation*

Total Annual Cash Compensation$560,000
Total Short Term Compensation$560,000
Total Calculated Compensation$685,403
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CALA:US $6.05 USD +0.06


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALITHERA BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at